FINCK BARBARA K 4
4 · Coherus BioSciences, Inc. · Filed Jul 11, 2018
Insider Transaction Report
Form 4
FINCK BARBARA K
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2018-07-09$1.42/sh+500$710→ 37,543 total - Exercise/Conversion
Stock Option (right to buy)
2018-07-09−500→ 87,721 totalExercise: $1.42Exp: 2023-11-23→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock, $0.0001 par value
2018-07-10$1.42/sh+1,260$1,789→ 38,303 total - Exercise/Conversion
Stock Option (right to buy)
2018-07-10−1,260→ 86,461 totalExercise: $1.42Exp: 2023-11-21→ Common Stock (1,260 underlying) - Sale
Common Stock, $0.0001 par value
2018-07-09$15.03/sh−500$7,515→ 37,043 total - Sale
Common Stock, $0.0001 par value
2018-07-10$15.00/sh−1,260$18,900→ 37,043 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]The shares underlying this option are fully vested and exercisable as of the date hereof.